| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.0068 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |